Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03627546 · ClinicalTrials.gov registry record · NA

HCV Seek, Test and Rapid Treatment for Young PWID

A NA study of Hepatitis C and Drug Use, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT03627546 is a NA study of Hepatitis C and Drug Use that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 39 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03627546, a NA study of Hepatitis C and Drug Use, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized study is to determine whether a community-based test and treat model of hepatitis C (HCV) care delivery will be superior to the usual care practice of referral to specialist clinics for the outcomes of sustained virologic response at 12 weeks after treatment and initiation of HCV treatment for persons who inject drugs (PWID) between ages 18 and 29 who are naïve to HCV treatment

Conditions Studied

Interventions

  • OTHER Rapid Treatment strategy
  • OTHER Usual Care (facilitated referral)

Study Locations (1)

New York

  • Lower East Side Harm Reduction Center - New York

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2018-09-18
Est. Completion 2021-06-30
Phase NA

What the Registry Record Tells You About NCT03627546

The ClinicalTrials.gov registry entry for NCT03627546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (98% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 2 interventions - of which Rapid Treatment strategy is the first listed.

NCT03627546 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03627546 about?

NCT03627546 is a clinical study titled "HCV Seek, Test and Rapid Treatment for Young PWID". The purpose of this randomized study is to determine whether a community-based test and treat model of hepatitis C (HCV) care delivery will be superior to the usual care practice of referral to specialist clinics for the outcomes of sustained virologic response at 12 weeks after treatment and initia...

What is the current status of trial NCT03627546?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-09-18. Estimated completion is 2021-06-30.

What conditions does trial NCT03627546 study?

This clinical trial studies the following conditions: Hepatitis C, Drug Use.

What interventions are being tested in trial NCT03627546?

The interventions under investigation include: Rapid Treatment strategy (OTHER), Usual Care (facilitated referral) (OTHER).

Who is sponsoring clinical trial NCT03627546?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03627546 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.